Talimogene Laherparepvec, Nivolumab and Trabectedin for Sarcoma — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Talimogene Laherparepvec, Nivolumab and Trabectedin for Sarcoma — Stella

View on ClinicalTrials.gov

Recruiting

Back to Sarcoma trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

Sarcoma Oncology Center, Santa Monica, California

Key details

Phase

Safety & dosing

Sponsor

Sarcoma Oncology Research Center, LLC

Enrollment target

~200 participants

Started

May 2019

Primary completion

December 2030

Age range

18 Years and older

Last updated February 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.